Development and validation of a circulating tumor DNA-based optimization-prediction model for short-term postoperative recurrence of endometrial cancer

doi:10.12998/wjcc.v12.i18.3385

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (431)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

HTML

327

Figures (1-6)

Tables (1-3)

Sum=396

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=23

Jun 26, 2024 (publication date) through Jun 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jun 26, 2024; 12(18): 3385-3394
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3385

Development and validation of a circulating tumor DNA-based optimization-prediction model for short-term postoperative recurrence of endometrial cancer

Yuan Liu, Xiao-Ning Lu, Hui-Ming Guo, Chan Bao, Juan Zhang, Yu-Ni Jin

Yuan Liu, Xiao-Ning Lu, Hui-Ming Guo, Chan Bao, Juan Zhang, Yu-Ni Jin, Department of Gynaecology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan Province, China

Author contributions: Liu Y and Jin YN designed the research and wrote the first manuscript; Lu XN, Guo HM, Bao C and Zhang J conceived the research and analyzed the data; Liu Y and Jin YN conducted the analysis and provided guidance for the research; All authors reviewed and approved the final manuscript.

Institutional review board statement: This study was reviewed and approved by the First Affiliated Hospital of Kunming Medical University.

Informed consent statement: Patients did not need to provide informed consent for the study, as anonymous clinical data were used for analysis.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: The data used in the above analysis are available upon reasonable request from the corresponding authors at yunnijin2024@126.com.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Yu-Ni Jin, MM, Associate Chief Physician, Department of Gynaecology, The First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming 650032, Yunnan Province, China. yunnijin2024@126.com

Received: March 7, 2024
Revised: April 23, 2024
Accepted: May 10, 2024
Published online: June 26, 2024
Processing time: 103 Days and 0.8 Hours

Core Tip

Core Tip: This study introduces a predictive nomogram for endometrial cancer recurrence postsurgery, incorporating circulating tumor DNA, carcinoembryonic antigen 125, and tumor grade. The model, validated through receiver operating characteristic and decision curve analysis, accurately forecasts short-term recurrence-free survival and aids in risk stratification.